Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
about
Immune responses to human cancer stem-like cells/cancer-initiating cellsPositive and negative regulation by NK cells in cancerDynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaIonizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cellsNatural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and KillingNK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeTargeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survivalHuman U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand.Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursTherapeutic potential and challenges of natural killer cells in treatment of solid tumorsThe Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells.ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.Hide-and-seek: the interplay between cancer stem cells and the immune system.Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity.An overview of therapeutic approaches to brain tumor stem cellsDifferential Targeting of Stem Cells and Differentiated Glioblastomas by NK CellsDual IRE1 RNase functions dictate glioblastoma development.Temozolomide increases MHC-I expression via NF-κB signaling in glioma stem cells.Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions.Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1
P2860
Q26781794-3EE3DA21-B9E7-4E6B-B596-6C4FC57AECFCQ27004658-1ACCA1FF-6749-4F68-916C-340053C7E072Q27344690-788A65C3-95F7-4FC7-B9E8-92737F17093FQ34662363-DE1463C4-FF50-4713-B9E0-CFF4962087F7Q35719080-5B198594-9B00-4736-81F8-D970D2094C92Q35743681-F641779D-8002-4A9B-A15D-9FF182659AB7Q35878535-8C501B73-B161-4A7A-ACE1-780BED9A1165Q35984406-06AD5ED4-5509-43A0-ACD5-3BA376EEC11AQ35988225-A81F1AC5-98F9-48FF-867C-6E427650C2C3Q36118290-935C1A7D-0D1D-4A40-A63C-6D19E61C4F95Q36660550-5E134F86-3841-49ED-859E-5E843995C69AQ37299271-6EB9134B-F4DB-4BAB-8A75-A094692FB047Q37637062-B299B4DB-426F-480A-A461-A849683B1A06Q38148501-16D9B55C-2EE3-4908-8FCA-FC222B72E101Q38478878-BD17708E-095E-4702-8039-DE733EED0221Q38652319-11D2D9E6-847E-4328-BEEE-C6D8C5BD05E4Q38712677-D0DD2774-2E4A-4276-9F5A-949EF91CDEB1Q38814097-EB3A119A-3108-47C9-9F87-4CC787515BEAQ38941698-036A33D8-212F-49C0-8B22-8BBA7F9D4293Q39014465-115ED621-1803-43B4-9990-A909CD1BD5ACQ39208487-DF506A06-CC32-484C-BFAD-118C056171B3Q39252478-7AA82ADC-E9A7-4F0A-B037-EF4E1B0F04E0Q41475241-985DE0AD-06B7-490C-8D70-DE24D87EDC6FQ41623263-AEA268BB-805A-4E59-838D-4269E685E26BQ42281984-378C20BE-AA43-4A9D-A104-4E676B23D064Q47223132-F07186DF-EADB-4387-8A6B-C477C97BB8A0Q50732365-721C781F-920D-462D-875A-9EAD808281E2Q52716439-D916F642-9D75-480B-85CD-A4AD7AD4259FQ55419590-6D7C841E-57DC-434A-BE4A-0AE729E20545Q58695414-FA107E8A-B471-4E79-918B-403EF6FCD73E
P2860
Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@en
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@nl
type
label
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@en
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@nl
prefLabel
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@en
Human glioblastoma stem-like c ...... m-cultured glioblastoma cells.
@nl
P2093
P2860
P1433
P1476
Human glioblastoma stem-like c ...... um-cultured glioblastoma cells
@en
P2093
Abderrahmane Hamlat
Amandine Etcheverry
Caroline Delmas
Elodie Vauleon
Jean Mosser
Stéphan Saikali
Sylma Diabira
Tony Avril
P2860
P304
P356
10.1111/J.1750-3639.2011.00515.X
P577
2011-09-16T00:00:00Z